Table 5.
Trends of hazards of 5-year overall survival characteristics in the female group.
| 5-year OS | 1994–2006 | 2007–2019 | |||
|---|---|---|---|---|---|
| Characteristics | Male | Female | Male | Female | P-value |
| Survival or death rate | |||||
| Death | 62.2% | 61.7% | 43.3% | 49.4% | n.s. |
| Age, years | |||||
| ≥60 | 51.6% | 33.7% | 51.1% | 38.4% | n.s. |
| Borrmann | |||||
| Type IV | 9.7% | 6.0% | 11.1% | 17.4% | <0.0001 |
| Hospitalization, days | |||||
| >15 | 32.0% | 38.2% | 16.9% | 8.4% | n.s. |
| Peritoneal metastasis | |||||
| P1 | 12.9% | 18.3% | 10.9% | 12.2% | n.s. |
| Hepatic metastasis | |||||
| H1 | 5.4% | 5.7% | 2.0% | 2.4% | n.s. |
| Tumor location | |||||
| A single part of the stomach | 72.4% | 67.9% | 75.7% | 71.3% | n.s. |
| Histological type | |||||
| Poor differentiation | 68.4% | 80.6% | 70.0% | 81.9% | n.s. |
| Pathological type | |||||
| Adenocarcinoma | 64.5% | 35.5% | 64.5% | 35.5% | n.s. |
| T status | |||||
| T4 | 54.4% | 56.2% | 16.9% | 16.7% | n.s. |
| pTNM | |||||
| IV | 25.8% | 31.5% | 19.8% | 21.3% | n.s. |
| N stage | |||||
| N1 | 65.5% | 65.3% | 61.9% | 66.5% | n.s. |
Chi-square tests were used in the calculation.
n.s., not significant.
The bold values means significant meanings.